PROPHECY SURGICAL ICU EXAM SCRIPT
EXPERT CERTIFIED QUESTIONS AND
CORRECT ANSWERS GRADED A+
⩥ Malignant Tumors.
Answer: Cancerous tumors that can invade and spread.
⩥ Benign Tumors.
Answer: Non-cancerous tumors that usually do not spread or return after
removal.
⩥ Carcinomas.
Answer: Begin in skin or tissues lining internal organs (e.g., breast
cancer).
⩥ Sarcomas.
Answer: Start in bone, muscle, cartilage, fat, blood vessels, or supportive
tissue.
⩥ Leukemias.
Answer: Originate in blood-forming tissues (bone marrow), producing
abnormal cells entering bloodstream.
,⩥ Lymphoma/Myeloma.
Answer: Begin in immune system cells.
⩥ CNS tumors.
Answer: Form in brain or spinal cord tissues.
⩥ Stage 0 Cancer.
Answer: Localized, within origin tissue.
⩥ Stage I Cancer.
Answer: Small, localized.
⩥ Stage II Cancer.
Answer: Larger, with local invasion/lymph node involvement.
⩥ Stage III Cancer.
Answer: Greater burden, wider spread/lymph node involvement.
⩥ Stage IV Cancer.
Answer: Metastatic, involves distant organs.
⩥ Surgery.
,Answer: Diagnostic, curative (remove tumor or reduce bulk), or
palliative (relieve symptoms).
⩥ Chemotherapy.
Answer: Delivered IV or intrathecally, targets rapidly dividing cells;
may occur in cycles; special delivery devices (Ommaya reservoir,
intrahepatic).
⩥ HIPEC.
Answer: Hyperthermic intraperitoneal chemotherapy; part of surgical
approach for abdominal cancers.
⩥ Radiation.
Answer: Damages DNA of cancer cells, can be external or internal
(brachytherapy); used for curative or palliative purposes.
⩥ Immunotherapy.
Answer: Harnesses immune system to target and destroy cancer.
⩥ Hormonal therapy.
Answer: Blocks hormones that stimulate tumor growth—used for breast,
prostate, ovarian, uterine cancers.
⩥ Stem Cell Transplant.
, Answer: Used for blood cancers (leukemia, lymphoma, myeloma,
MDS); types include autologous (self), allogenic (donor), syngeneic
(twin)
⩥ Surgical Oncology.
Answer: For diagnostic, staging, removal, reconstruction, palliation,
chemotherapy, prevention
⩥ Chemotherapy side effects.
Answer: Bone marrow suppression, nausea, vomiting, diarrhea, hair
loss, skin and nail changes, LOA, weight loss, changes in taste, mouth
and throat soreness, ulcers, constipation, fatigue, heart, liver, lung,
kidney damage, nervous system changes: central and peripheral,
cognitive changes: CICI, reproduction and sexuality changes
⩥ Radiation Goals.
Answer: Curative, prophylactic/preventative, palliative
⩥ Radiation Side Effects.
Answer: Immediate: Fatigue, skin changes, dermatitis, burns, redness,
dry and peeling skin, sores/ulcers, inflammation/infection, internal
damage; Late: Fibrosis, joint dysfunction, intestinal damage, memory
loss, lymphedema, secondary cancer, peripheral neuropathy
⩥ Immunotherapy Side Effects.
EXPERT CERTIFIED QUESTIONS AND
CORRECT ANSWERS GRADED A+
⩥ Malignant Tumors.
Answer: Cancerous tumors that can invade and spread.
⩥ Benign Tumors.
Answer: Non-cancerous tumors that usually do not spread or return after
removal.
⩥ Carcinomas.
Answer: Begin in skin or tissues lining internal organs (e.g., breast
cancer).
⩥ Sarcomas.
Answer: Start in bone, muscle, cartilage, fat, blood vessels, or supportive
tissue.
⩥ Leukemias.
Answer: Originate in blood-forming tissues (bone marrow), producing
abnormal cells entering bloodstream.
,⩥ Lymphoma/Myeloma.
Answer: Begin in immune system cells.
⩥ CNS tumors.
Answer: Form in brain or spinal cord tissues.
⩥ Stage 0 Cancer.
Answer: Localized, within origin tissue.
⩥ Stage I Cancer.
Answer: Small, localized.
⩥ Stage II Cancer.
Answer: Larger, with local invasion/lymph node involvement.
⩥ Stage III Cancer.
Answer: Greater burden, wider spread/lymph node involvement.
⩥ Stage IV Cancer.
Answer: Metastatic, involves distant organs.
⩥ Surgery.
,Answer: Diagnostic, curative (remove tumor or reduce bulk), or
palliative (relieve symptoms).
⩥ Chemotherapy.
Answer: Delivered IV or intrathecally, targets rapidly dividing cells;
may occur in cycles; special delivery devices (Ommaya reservoir,
intrahepatic).
⩥ HIPEC.
Answer: Hyperthermic intraperitoneal chemotherapy; part of surgical
approach for abdominal cancers.
⩥ Radiation.
Answer: Damages DNA of cancer cells, can be external or internal
(brachytherapy); used for curative or palliative purposes.
⩥ Immunotherapy.
Answer: Harnesses immune system to target and destroy cancer.
⩥ Hormonal therapy.
Answer: Blocks hormones that stimulate tumor growth—used for breast,
prostate, ovarian, uterine cancers.
⩥ Stem Cell Transplant.
, Answer: Used for blood cancers (leukemia, lymphoma, myeloma,
MDS); types include autologous (self), allogenic (donor), syngeneic
(twin)
⩥ Surgical Oncology.
Answer: For diagnostic, staging, removal, reconstruction, palliation,
chemotherapy, prevention
⩥ Chemotherapy side effects.
Answer: Bone marrow suppression, nausea, vomiting, diarrhea, hair
loss, skin and nail changes, LOA, weight loss, changes in taste, mouth
and throat soreness, ulcers, constipation, fatigue, heart, liver, lung,
kidney damage, nervous system changes: central and peripheral,
cognitive changes: CICI, reproduction and sexuality changes
⩥ Radiation Goals.
Answer: Curative, prophylactic/preventative, palliative
⩥ Radiation Side Effects.
Answer: Immediate: Fatigue, skin changes, dermatitis, burns, redness,
dry and peeling skin, sores/ulcers, inflammation/infection, internal
damage; Late: Fibrosis, joint dysfunction, intestinal damage, memory
loss, lymphedema, secondary cancer, peripheral neuropathy
⩥ Immunotherapy Side Effects.
